Report Detail

Other Global Prostate Cancer Therapeutics Drugs Market Size, Status and Forecast 2025

  • RnM1738045
  • |
  • 16 March, 2018
  • |
  • Global
  • |
  • 91 pages
  • |
  • QYResearch
  • |
  • Other

Global Prostate Cancer Therapeutics Drugs Market Size, Status and Forecast 2025

Table of Contents

    Global Prostate Cancer Therapeutics Drugs Market Size, Status and Forecast 2025

      1 Industry Overview of Prostate Cancer Therapeutics Drugs

      • 1.1 Prostate Cancer Therapeutics Drugs Market Overview
        • 1.1.1 Prostate Cancer Therapeutics Drugs Product Scope
        • 1.1.2 Market Status and Outlook
      • 1.2 Global Prostate Cancer Therapeutics Drugs Market Size and Analysis by Regions (2013-2018)
        • 1.2.1 United States
        • 1.2.2 EU
        • 1.2.3 Japan
        • 1.2.4 China
        • 1.2.5 India
        • 1.2.6 Southeast Asia
      • 1.3 Prostate Cancer Therapeutics Drugs Market by Type
        • 1.3.1 Hormone Therapy
        • 1.3.2 Chemotherapy
        • 1.3.3 Biologic Therapy
        • 1.3.4 Targeted Therapy
        • 1.3.5 Other
      • 1.4 Prostate Cancer Therapeutics Drugs Market by End Users/Application
        • 1.4.1 Hospital Pharmacy
        • 1.4.2 Retail Pharmacy
        • 1.4.3 Online Sales
        • 1.4.4 Other

      2 Global Prostate Cancer Therapeutics Drugs Competition Analysis by Players

      • 2.1 Prostate Cancer Therapeutics Drugs Market Size (Value) by Players (2013-2018)
      • 2.2 Competitive Status and Trend
        • 2.2.1 Market Concentration Rate
        • 2.2.2 Product/Service Differences
        • 2.2.3 New Entrants
        • 2.2.4 The Technology Trends in Future

      3 Company (Top Players) Profiles

      • 3.1 Johnson & Johnson
        • 3.1.1 Company Profile
        • 3.1.2 Main Business/Business Overview
        • 3.1.3 Products, Services and Solutions
        • 3.1.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.1.5 Recent Developments
      • 3.2 Pfizer, Inc
        • 3.2.1 Company Profile
        • 3.2.2 Main Business/Business Overview
        • 3.2.3 Products, Services and Solutions
        • 3.2.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.2.5 Recent Developments
      • 3.3 AstraZeneca
        • 3.3.1 Company Profile
        • 3.3.2 Main Business/Business Overview
        • 3.3.3 Products, Services and Solutions
        • 3.3.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.3.5 Recent Developments
      • 3.4 Amgen, Inc
        • 3.4.1 Company Profile
        • 3.4.2 Main Business/Business Overview
        • 3.4.3 Products, Services and Solutions
        • 3.4.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.4.5 Recent Developments
      • 3.5 AbbVie, Inc
        • 3.5.1 Company Profile
        • 3.5.2 Main Business/Business Overview
        • 3.5.3 Products, Services and Solutions
        • 3.5.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.5.5 Recent Developments
      • 3.6 Bayer AG
        • 3.6.1 Company Profile
        • 3.6.2 Main Business/Business Overview
        • 3.6.3 Products, Services and Solutions
        • 3.6.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.6.5 Recent Developments
      • 3.7 Ipsen Group
        • 3.7.1 Company Profile
        • 3.7.2 Main Business/Business Overview
        • 3.7.3 Products, Services and Solutions
        • 3.7.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.7.5 Recent Developments
      • 3.8 Sanofi
        • 3.8.1 Company Profile
        • 3.8.2 Main Business/Business Overview
        • 3.8.3 Products, Services and Solutions
        • 3.8.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.8.5 Recent Developments
      • 3.9 Endo Pharmaceuticals
        • 3.9.1 Company Profile
        • 3.9.2 Main Business/Business Overview
        • 3.9.3 Products, Services and Solutions
        • 3.9.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.9.5 Recent Developments
      • 3.10 Dendreon Corporation
        • 3.10.1 Company Profile
        • 3.10.2 Main Business/Business Overview
        • 3.10.3 Products, Services and Solutions
        • 3.10.4 Prostate Cancer Therapeutics Drugs Revenue (Million USD) (2013-2018)
        • 3.10.5 Recent Developments

      4 Global Prostate Cancer Therapeutics Drugs Market Size by Type and Application (2013-2018)

      • 4.1 Global Prostate Cancer Therapeutics Drugs Market Size by Type (2013-2018)
      • 4.2 Global Prostate Cancer Therapeutics Drugs Market Size by Application (2013-2018)
      • 4.3 Potential Application of Prostate Cancer Therapeutics Drugs in Future
      • 4.4 Top Consumer/End Users of Prostate Cancer Therapeutics Drugs

      5 United States Prostate Cancer Therapeutics Drugs Development Status and Outlook

      • 5.1 United States Prostate Cancer Therapeutics Drugs Market Size (2013-2018)
      • 5.2 United States Prostate Cancer Therapeutics Drugs Market Size and Market Share by Players (2013-2018)
      • 5.3 United States Prostate Cancer Therapeutics Drugs Market Size by Application (2013-2018)

      6 EU Prostate Cancer Therapeutics Drugs Development Status and Outlook

      • 6.1 EU Prostate Cancer Therapeutics Drugs Market Size (2013-2018)
      • 6.2 EU Prostate Cancer Therapeutics Drugs Market Size and Market Share by Players (2013-2018)
      • 6.3 EU Prostate Cancer Therapeutics Drugs Market Size by Application (2013-2018)

      7 Japan Prostate Cancer Therapeutics Drugs Development Status and Outlook

      • 7.1 Japan Prostate Cancer Therapeutics Drugs Market Size (2013-2018)
      • 7.2 Japan Prostate Cancer Therapeutics Drugs Market Size and Market Share by Players (2013-2018)
      • 7.3 Japan Prostate Cancer Therapeutics Drugs Market Size by Application (2013-2018)

      8 China Prostate Cancer Therapeutics Drugs Development Status and Outlook

      • 8.1 China Prostate Cancer Therapeutics Drugs Market Size (2013-2018)
      • 8.2 China Prostate Cancer Therapeutics Drugs Market Size and Market Share by Players (2013-2018)
      • 8.3 China Prostate Cancer Therapeutics Drugs Market Size by Application (2013-2018)

      9 India Prostate Cancer Therapeutics Drugs Development Status and Outlook

      • 9.1 India Prostate Cancer Therapeutics Drugs Market Size (2013-2018)
      • 9.2 India Prostate Cancer Therapeutics Drugs Market Size and Market Share by Players (2013-2018)
      • 9.3 India Prostate Cancer Therapeutics Drugs Market Size by Application (2013-2018)

      10 Southeast Asia Prostate Cancer Therapeutics Drugs Development Status and Outlook

      • 10.1 Southeast Asia Prostate Cancer Therapeutics Drugs Market Size (2013-2018)
      • 10.2 Southeast Asia Prostate Cancer Therapeutics Drugs Market Size and Market Share by Players (2013-2018)
      • 10.3 Southeast Asia Prostate Cancer Therapeutics Drugs Market Size by Application (2013-2018)

      11 Market Forecast by Regions, Type and Application (2018-2025)

      • 11.1 Global Prostate Cancer Therapeutics Drugs Market Size (Value) by Regions (2018-2025)
        • 11.1.1 United States Prostate Cancer Therapeutics Drugs Revenue and Growth Rate (2018-2025)
        • 11.1.2 EU Prostate Cancer Therapeutics Drugs Revenue and Growth Rate (2018-2025)
        • 11.1.3 Japan Prostate Cancer Therapeutics Drugs Revenue and Growth Rate (2018-2025)
        • 11.1.4 China Prostate Cancer Therapeutics Drugs Revenue and Growth Rate (2018-2025)
        • 11.1.5 India Prostate Cancer Therapeutics Drugs Revenue and Growth Rate (2018-2025)
        • 11.1.6 Southeast Asia Prostate Cancer Therapeutics Drugs Revenue and Growth Rate (2018-2025)
      • 11.2 Global Prostate Cancer Therapeutics Drugs Market Size (Value) by Type (2018-2025)
      • 11.3 Global Prostate Cancer Therapeutics Drugs Market Size by Application (2018-2025)

      12 Prostate Cancer Therapeutics Drugs Market Dynamics

      • 12.1 Prostate Cancer Therapeutics Drugs Market Opportunities
      • 12.2 Prostate Cancer Therapeutics Drugs Challenge and Risk
        • 12.2.1 Competition from Opponents
        • 12.2.2 Downside Risks of Economy
      • 12.3 Prostate Cancer Therapeutics Drugs Market Constraints and Threat
        • 12.3.1 Threat from Substitute
        • 12.3.2 Government Policy
        • 12.3.3 Technology Risks
      • 12.4 Prostate Cancer Therapeutics Drugs Market Driving Force
        • 12.4.1 Growing Demand from Emerging Markets
        • 12.4.2 Potential Application

      13 Market Effect Factors Analysis

      • 13.1 Technology Progress/Risk
        • 13.1.1 Substitutes
        • 13.1.2 Technology Progress in Related Industry
      • 13.2 Consumer Needs Trend/Customer Preference
      • 13.3 External Environmental Change
        • 13.3.1 Economic Fluctuations
        • 13.3.2 Other Risk Factors

      14 Research Finding/Conclusion

        15 Appendix

          Methodology

            Analyst Introduction

              Data Source

              This report studies the global Prostate Cancer Therapeutics Drugs market, analyzes and researches the Prostate Cancer Therapeutics Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
              Johnson & Johnson
              Pfizer, Inc
              AstraZeneca
              Amgen, Inc
              AbbVie, Inc
              Bayer AG
              Ipsen Group
              Sanofi
              Endo Pharmaceuticals
              Dendreon Corporation

              Market segment by Regions/Countries, this report covers
              United States
              EU
              Japan
              China
              India
              Southeast Asia

              Market segment by Type, the product can be split into
              Hormone Therapy
              Chemotherapy
              Biologic Therapy
              Targeted Therapy
              Other

              Market segment by Application, Prostate Cancer Therapeutics Drugs can be split into
              Hospital Pharmacy
              Retail Pharmacy
              Online Sales
              Other

              If you have any special requirements, please let us know and we will offer you the report as you want.



              REPORT YOU MIGHT BE INTERESTED

              Purchase this Report

              $3,300.00
              $6,600.00
              2,709.96
              5,419.92
              2,975.81
              5,951.62
              351,436.80
              702,873.60
              236,744.97
              473,489.94
              Credit card Logo

              Related Reports


              Reason to Buy

              Request for Sample of this report